Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial
- Submitting institution
-
Queen Mary University of London
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 2020
- Type
- D - Journal article
- DOI
-
10.1200/JCO.19.00368
- Title of journal
- Journal of Clinical Oncology
- Article number
- -
- First page
- 423
- Volume
- 38
- Issue
- 5
- ISSN
- 0732-183X
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
28
- Research group(s)
-
B - Barts Cancer
- Citation count
- 34
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
